CSPC 2018 has ended
avatar for Dr. Raphael (Rafi) Hofstein

Dr. Raphael (Rafi) Hofstein

MaRS Innovation
President and CEO

Dr. Raphael Hofstein, also known as Rafi, Ph.D. has been the Chief Executive Officer and President of MaRS Innovation since June 2009.

Dr. Hofstein joined MaRS Innovation from Israel, where he held the position of President and CEO of Hadasit Ltd., the technology transfer company of the Hadassah Medical Organization in Jerusalem, since 1999.  He has also served as Chair of Hadasit BioHolding Ltd., publicly traded on the Tel Aviv Stock Exchange (TASE), since 2005.  In these roles, he was responsible for the commercialization of intellectual property emerging from the Hadassah Medical Organization, clinical trials with industry partners, as well as the launch, development and strategic oversight of a series of medical devices, biomedicine and diagnostic equipment spin-off companies. He has also served as chairman of BIOMED, Israel’s annual biomedical conference, from 2005 to 2007. In addition, Dr. Hofstein is a co-founder and board member of ILSI, the Israeli Life Science Industry Organization, and a co-founder and executive of Israel’s Tech Transfer Network (ITTN).

Dr. Hofstein is currently a member of the board of directors of Life Science Ontario and of Clinical Trials Ontario as well as a member of the Organizing Committee of the Public Policy Forum on Venture Capital and Innovation (part of the Quebec City Conference).